BUSINESS

• Takeda, ANA to Test Drone Drug Delivery to Remote Islands in Nagasaki
  March 12, 2021

• Kobayashi Kako to Invite Outsider to Take Over Top Post: Biz Improvement Plan
  March 11, 2021

• Nichi-Iko to Stop Supply of 4 APIs/8 Products as Stocks Run Out
  March 11, 2021

• JMA Affiliate Data Operator Poised to Provide RWD from NHO Hospitals to Drug Makers
  March 11, 2021

• Takeda to Buy Out T-Cell Engager Specialist Maverick for US$525 Million
  March 11, 2021

• Nichi-Iko Drug Supply Delayed as Customers Flock to Place Orders
  March 10, 2021

• 70% of Major Products Fall Victim to Off-Year Drug Re-Pricing: Jiho Tally
  March 10, 2021

• JCR Terminates Temcell Development for Epidermolysis Bullosa
  March 10, 2021

• Top-Tier Drug Makers Face 2-4% Cuts, Mid-Sized Firms 6-8% in Japan’s First Off-Year Re-Pricing: Tally
  March 9, 2021

• Top-3 Generic Makers Hit with Average 9.8% Price Cut in Off-Year Revision: Jiho Tally
  March 9, 2021

• Rohto Kicks Off Japan PIIa of JAK Inhibitor Delgocitinib for Dry Eye Symptoms
  March 9, 2021

• Takeda Aims for Mid-Teens Annual Growth in Japan Oncology Biz: Exec
  March 8, 2021

• Viatris Rolls Out 3 Follow-On AGs for Norvasc, Cardenalin, Relpax
  March 8, 2021

• Japan Ethical Drug Sales Down 5.3% in January: Crecon
  March 8, 2021

• Sumitomo Dainippon Ditches Napabucasin, 27 Billion Yen Impairment Loss to Be Incurred in FY2021
  March 8, 2021

• Takeda Submits NDA for Moderna Vaccine in Japan
  March 5, 2021

• Nichi-Iko’s Shipment Halt for 9 APIs Was Due to Biz Suspension
  March 5, 2021

• Takeda Takes Back Rare Epilepsy Drug in Revised Deal with Ovid
  March 5, 2021

• JCR to Build New Manufacturing Facility for COVID-19 Vaccine
  March 5, 2021

• Alesion Top-Selling Drug in February: Encise
  March 5, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 242
• 243
• 244
• 245
• 246
• 247
• 248
• 249
• 250
• …
• Next ›
• 最終 »